川能動力(000155.SZ):馬爾康新能源擬投建阿壩馬爾康日部英郎光伏發電項目
格隆匯3月28日丨川能動力(000155.SZ)公佈,公司第九屆董事會第三次會議審議通過,同意控股子公司馬爾康川能新能源開發有限公司(簡稱“馬爾康新能源”或“項目公司”)投資建設阿壩馬爾康日部英郎光伏發電項目。
馬爾康英郎光伏項目場址位於四川省阿壩藏族羌族自治州馬爾康市日部鄉境內,場地海拔高程3500m-4400m,項目裝機容量爲300MW。建設工程包括300MW光伏電站及220KV送出工程,其中光伏電站投資不超過139,489.14萬元。計劃建設週期爲16個日曆月(扣除施工冬歇期),項目運營週期25年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.